(108) found that CXCL16 participated in the blockage of the complement C5A/C5AR axis in lung cancer bone metastasis, suggesting that CXCL16 is also a potential biomarker for the prediction of lung cancer progression and bone metastasis. The gene discussed is C5AR1; the disease is lung carcinoma.